Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseCarl K. Hoh, Michael E. Phelps, Randall A. Hawkins et al.|Journal of Computer Assisted Tomography|1993Cited by 255
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.Deog Hwan Moon, Carl K. Hoh, Daniel Silverman et al.|PubMed|1998Cited by 249
PET in oncology: Will it replace the other modalities?Carl K. Hoh, Michael E. Phelps, Christiaan Schiepers et al.|Seminars in Nuclear Medicine|1997Cited by 212
The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseNielson Tse, John A. Glaspy, Carl K. Hoh et al.|Annals of Surgery|1992Cited by 182
Phase I, First-in-Human Study of BMS747158, a Novel <sup>18</sup>F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at RestJamshid Maddahi, Michael E. Phelps, Johannes Czernin et al.|Journal of Nuclear Medicine|2011Cited by 134